Search

everythinglearnresearchcommunity

for

Search:↓

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Targeting NETs may help reduce fibrosis in Crohn's disease.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

A new therapy for a skin blistering condition has not been developed yet.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Janus kinase inhibitors may help treat lichen planopilaris.

Invasomes with natural terpenes can improve drug delivery through the skin.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

JAK inhibitors offer new hope for treating severe alopecia areata.